Replies to post #3288 on GTC Biotherapeutics (fka GTCB)

[gym gravity]

Do you attend?

Free pizza?

[gym gravity]

looking up Dr. Bauer:

http://www.bidmc.harvard.edu/content/bidmc/Departments/Medicine/Hemostasis_Thrombosis/hemostasis%20a....

The Division maintains
an outpatient specialty clinic, the Hemophilia
and Thrombosis Clinical Center. Patients are
seen weekly with fellows by Drs. Furie, Roth,
Bauer and Flaumenhaft. This clinic represents
a referral center for patients with bleeding or
thrombotic disorders, approximately 50 percent
of whom are referred from physicians outside of
Massachusetts. Many of these patients elect to
have surgery at Beth Israel Deaconess Medical
Center under the indirect care of faculty in this
Division. Dr. Roth participates part-time, having
moved to a senior position at Wyeth. Dr. Robert
Flaumenhaft has joined this practice in 2006. Dr.
Bauer is Director of Thrombosis Clinical Research.
A number of clinical trials are closely integrated
into this clinical program.



(my wife is a doc at BIDMC)

[DewDiligence]

Current Insider Shareholdings and Options

[As of the Apr 5, 2007 cutoff date used in the annual-meeting proxy.
Options include those that are exercisable now or within 60 days.]

 
  
 Executive Officers  
 Geoffrey Cox, CEO          250K shares   722K options 
 John Green, CFO            109K shares   307K options 
 Harry Meade, SVP Research  107K shares   268K options 
 Dan Woloshen, Gen. Counsel  81K shares   190K options 
 Greg Liposky, SVP Oprtns    51K shares   246K options 
 Dick Scotland, SVP Regltry  67K shares   129K options 
 -- 
 Six executive officers     665K shares 1,852K options

 
 Independent directors  
 Robert Baldridge             5K shares    60K options 
 Kenneth Bauer                 0 shares    30K options 
 Christian Béchon             3K shares     8k options 
 Francis Bullock              5K shares    66K options 
 James Geraghty              70K shares   148K options 
 Michael Landine               0 shares    23K options 
 Pamela McNamara              6K shares    45K options 
 Marvin Miller                5K shares    45K options 
 Alan Tuck                   11K shares    43K options 
 -- 
 Nine independent directors 105K shares   468K options

 
 All officers/directors     770K shares 2,320K options